Company
Moleculera Biosciences
Reshaping the future of medicine.
Also known as Moleculera Biosciences, Inc
- Status
- Operatingas of 2026-09-20
- Business model
- B2B
- Customers
- clinicians
- Legal name
- Moleculera Biosciences, Inc
- moleculeralabs.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 29 September 2026
About
Moleculera Biosciences®, is a precision medicine company founded to transform how medicine is practiced for patients suffering from chronic disorders driven by inflammation and immune dysfunction.
Funding snapshot
- Total raised
- $1MSum of rounds, as of 2026-09-20Source (opens in a new tab)
- Latest round
- Grant, $500K2024-10-30
Funding rounds
- Grant
- $500K2024-10-30, Company stated
- Grant
- $500K2024-01-11, Company stated
Products
- Other
- Alzheimer’s Early Intervention Inflammatory Biomarker Panel™
- Other
- Autoimmune Brain Panel™
- Other
- Autoimmune Cardiovascular Panel™
Loading relationship preview